Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1684 | 6769 | 34.6 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
1684 | 2 | METHOTREXATE//FOLATE RECEPTOR//REDUCED FOLATE CARRIER | 6769 |
2341 | 1 | REDUCED FOLATE CARRIER//FOLYLPOLYGLUTAMATE SYNTHETASE//ANTIFOLATE | 2275 |
3319 | 1 | METHOTREXATE//RHEUMATOID ARTHRITIS//METHOTREXATE POLYGLUTAMATES | 2010 |
10553 | 1 | FOLATE RECEPTOR//FOLATE BINDING PROTEIN//FOLATE RECEPTOR ALPHA | 1054 |
15824 | 1 | HIGH DOSE METHOTREXATE//7 HYDROXYMETHOTREXATE//METHOTREXATE | 690 |
19906 | 1 | TENIDAP//SULFASALAZINE//SULPHASALAZINE | 484 |
26370 | 1 | METHOTREXATE//INTESTINAL DAMAGE//ABSORPTIVE FUNCTION OF THE INTESTINE | 256 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | METHOTREXATE | authKW | 1256543 | 18% | 23% | 1217 |
2 | FOLATE RECEPTOR | authKW | 636641 | 4% | 58% | 245 |
3 | REDUCED FOLATE CARRIER | authKW | 325555 | 1% | 74% | 98 |
4 | ANTIFOLATE | authKW | 226539 | 2% | 39% | 129 |
5 | FOLYLPOLYGLUTAMATE SYNTHETASE | authKW | 163268 | 1% | 77% | 47 |
6 | FOLATE BINDING PROTEIN | authKW | 149374 | 1% | 61% | 54 |
7 | 7 HYDROXYMETHOTREXATE | authKW | 135891 | 1% | 84% | 36 |
8 | FOLATE RECEPTOR ALPHA | authKW | 132543 | 1% | 70% | 42 |
9 | PROTON COUPLED FOLATE TRANSPORTER | authKW | 114022 | 0% | 82% | 31 |
10 | METHOTREXATE POLYGLUTAMATES | authKW | 108391 | 0% | 96% | 25 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 76273 | 19% | 1% | 1314 |
2 | Oncology | 7362 | 19% | 0% | 1261 |
3 | Pharmacology & Pharmacy | 6488 | 20% | 0% | 1352 |
4 | Chemistry, Medicinal | 1404 | 5% | 0% | 339 |
5 | Dermatology | 828 | 3% | 0% | 215 |
6 | Biochemistry & Molecular Biology | 584 | 12% | 0% | 840 |
7 | Hematology | 363 | 3% | 0% | 208 |
8 | Medicine, General & Internal | 318 | 5% | 0% | 335 |
9 | Medicine, Research & Experimental | 271 | 4% | 0% | 243 |
10 | Medical Laboratory Technology | 266 | 1% | 0% | 88 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT CLIN THER EUT PROGRAM | 72122 | 0% | 57% | 28 |
2 | PROGRAM MOL PHARMACOL EXPT THER EUT | 36057 | 0% | 50% | 16 |
3 | FRED WYSZKOWSKI CANC | 26892 | 0% | 30% | 20 |
4 | AUTOIMMUNE SEROL | 22536 | 0% | 50% | 10 |
5 | PENNY COLE HEMATOL | 14428 | 0% | 80% | 4 |
6 | GRACE CANC DRUG | 14335 | 0% | 13% | 25 |
7 | RADIOPHARMACEUT SCI ETH PSI USZ | 12270 | 0% | 21% | 13 |
8 | TRANSLAT MED DIAGNOST | 12022 | 0% | 67% | 4 |
9 | ETH PSI USZ | 11588 | 0% | 43% | 6 |
10 | RHEUMATOL | 11524 | 5% | 1% | 327 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF RHEUMATOLOGY | 30476 | 4% | 2% | 295 |
2 | BRITISH JOURNAL OF RHEUMATOLOGY | 27760 | 2% | 5% | 117 |
3 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 16694 | 2% | 2% | 166 |
4 | ARTHRITIS AND RHEUMATISM | 10189 | 2% | 2% | 154 |
5 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 10120 | 2% | 2% | 112 |
6 | ANNALS OF THE RHEUMATIC DISEASES | 6877 | 2% | 1% | 118 |
7 | ADVANCES IN ENZYME REGULATION | 6308 | 0% | 5% | 29 |
8 | JOURNAL OF MEDICINAL CHEMISTRY | 6018 | 3% | 1% | 173 |
9 | SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 5781 | 1% | 2% | 62 |
10 | ZEITSCHRIFT FUR RHEUMATOLOGIE | 5543 | 1% | 2% | 54 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | METHOTREXATE | 1256543 | 18% | 23% | 1217 | Search METHOTREXATE | Search METHOTREXATE |
2 | FOLATE RECEPTOR | 636641 | 4% | 58% | 245 | Search FOLATE+RECEPTOR | Search FOLATE+RECEPTOR |
3 | REDUCED FOLATE CARRIER | 325555 | 1% | 74% | 98 | Search REDUCED+FOLATE+CARRIER | Search REDUCED+FOLATE+CARRIER |
4 | ANTIFOLATE | 226539 | 2% | 39% | 129 | Search ANTIFOLATE | Search ANTIFOLATE |
5 | FOLYLPOLYGLUTAMATE SYNTHETASE | 163268 | 1% | 77% | 47 | Search FOLYLPOLYGLUTAMATE+SYNTHETASE | Search FOLYLPOLYGLUTAMATE+SYNTHETASE |
6 | FOLATE BINDING PROTEIN | 149374 | 1% | 61% | 54 | Search FOLATE+BINDING+PROTEIN | Search FOLATE+BINDING+PROTEIN |
7 | 7 HYDROXYMETHOTREXATE | 135891 | 1% | 84% | 36 | Search 7+HYDROXYMETHOTREXATE | Search 7+HYDROXYMETHOTREXATE |
8 | FOLATE RECEPTOR ALPHA | 132543 | 1% | 70% | 42 | Search FOLATE+RECEPTOR+ALPHA | Search FOLATE+RECEPTOR+ALPHA |
9 | PROTON COUPLED FOLATE TRANSPORTER | 114022 | 0% | 82% | 31 | Search PROTON+COUPLED+FOLATE+TRANSPORTER | Search PROTON+COUPLED+FOLATE+TRANSPORTER |
10 | METHOTREXATE POLYGLUTAMATES | 108391 | 0% | 96% | 25 | Search METHOTREXATE+POLYGLUTAMATES | Search METHOTREXATE+POLYGLUTAMATES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GONEN, N , ASSARAF, YG , (2012) ANTIFOLATES IN CANCER THERAPY: STRUCTURE, ACTIVITY AND MECHANISMS OF DRUG RESISTANCE.DRUG RESISTANCE UPDATES. VOL. 15. ISSUE 4. P. 183 -210 | 258 | 72% | 85 |
2 | ZHAO, RB , GOLDMAN, ID , (2003) RESISTANCE TO ANTIFOLATES.ONCOGENE. VOL. 22. ISSUE 47. P. 7431-7457 | 227 | 74% | 145 |
3 | MATHERLY, LH , WILSON, MR , HOU, ZJ , (2014) THE MAJOR FACILITATIVE FOLATE TRANSPORTERS SOLUTE CARRIER 19A1 AND SOLUTE CARRIER 46A1: BIOLOGY AND ROLE IN ANTIFOLATE CHEMOTHERAPY OF CANCER.DRUG METABOLISM AND DISPOSITION. VOL. 42. ISSUE 4. P. 632 -649 | 172 | 82% | 6 |
4 | MATHERLY, LH , GOLDMAN, D , (2003) MEMBRANE TRANSPORT OF FOLATES.VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 66. VOL. 66. ISSUE . P. 403 -456 | 175 | 75% | 227 |
5 | ASSARAF, YG , (2007) MOLECULAR BASIS OF ANTIFOLATE RESISTANCE.CANCER AND METASTASIS REVIEWS. VOL. 26. ISSUE 1. P. 153-181 | 157 | 73% | 141 |
6 | HOU, ZJ , MATHERLY, LH , (2014) BIOLOGY OF THE MAJOR FACILITATIVE FOLATE TRANSPORTERS SLC19A1 AND SLC46A1.EXCHANGERS. VOL. 73. ISSUE . P. 175 -204 | 114 | 92% | 16 |
7 | MCGUIRE, JJ , (2003) ANTICANCER ANTIFOLATES: CURRENT STATUS AND FUTURE DIRECTIONS..CURRENT PHARMACEUTICAL DESIGN. VOL. 9. ISSUE 31. P. 2593 -2613 | 136 | 78% | 185 |
8 | ELNAKAT, H , RATNAM, M , (2004) DISTRIBUTION, FUNCTIONALITY AND GENE REGULATION OF FOLATE RECEPTOR ISOFORMS: IMPLICATIONS IN TARGETED THERAPY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 56. ISSUE 8. P. 1067-1084 | 112 | 81% | 296 |
9 | RAZ, S , STARK, M , ASSARAF, YG , (2016) FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE: A KEY DETERMINANT OF FOLATE HOMEOSTASIS AND ANTIFOLATE RESISTANCE IN CANCER.DRUG RESISTANCE UPDATES. VOL. 28. ISSUE . P. 43 -64 | 142 | 65% | 0 |
10 | ZHAO, RB , MATHERLY, LH , GOLDMAN, ID , (2009) MEMBRANE TRANSPORTERS AND FOLATE HOMEOSTASIS: INTESTINAL ABSORPTION AND TRANSPORT INTO SYSTEMIC COMPARTMENTS AND TISSUES.EXPERT REVIEWS IN MOLECULAR MEDICINE. VOL. 11. ISSUE . P. - | 118 | 66% | 104 |
Classes with closest relation at Level 2 |